hodgkin lymphoma highlights from ash 2023: nivo-avd versus bv-avd in patients with hl
Published 6 months ago • 157 plays • Length 1:21Download video MP4
Download video MP3
Similar videos
-
1:18
hodgkin lymphoma highlights at ash 2022 and future outlooks
-
1:41
swog s1826: nivolumab avd vs brentuximab vedotin avd for advanced stage hodgkin lymphoma
-
2:18
treating patients with advanced-stage hl in the frontline and relapsed settings in 2024
-
0:48
exciting lymphoma updates to expect at ash 2023
-
2:57
lymphoma highlights from ash 2021
-
14:06
hodgkin lymphoma (updated 2023) - crash! medical review series
-
6:20
asco 2023 highlights on adjuvant osimertinib in resected egfr mutated nsclc: the adaura trial
-
5:11
treatment for hodgekin’s lymphoma | yashoda hospitals hyderabad
-
1:37
the role of ctdna in hodgkin lymphoma
-
10:30
scd highlights at ash 2023: disease pathogenesis, ongoing clinical trials & novel gene therapies
-
5:25
asco 2023 highlights on nivolumab in advanced stage classic hodgkin lymphoma: the swog s1826 study
-
21:05
ash 2023 cll/lymphoma highlights – alpine, sequoia, swog-s1826, polarix update | dr. mazyar shadman
-
3:59
lymphoma highlights at ash 2020
-
2:14
top highlights from asco & eha 2023
-
1:37
brecadd versus beacopp in advanced hl: a german hodgkin study group investigation
-
1:20
improving patient outcomes in ctcl: clinical collaboration and novel agents
-
16:35
key highlights in mpns at ash 2023: novel agents & combinations, ongoing clinical trials, and more
-
4:41
asco 2023 rare lymphoma highlights: jackpot8, ielsg37, and mogamulizumab chop in atl
-
0:55
intracranial disease in hodgkin lymphoma: a case study
-
9:53
key highlights in amyloidosis at ash 2023: diagnosis & novel immunotherapeutic agents being explored